Following the World Health Organisation’s declaration of Mpox as a Public Health Emergency, India has taken precautionary measures, including heightened surveillance at airports and land borders, to prevent the spread of the virus. While no cases have been reported in the country, India is closely monitoring the situation and has designated hospitals for managing potential cases.
Results for: Public Health Emergency
The World Health Organization’s declaration of a public health emergency for the mpox outbreak has sent shockwaves through the healthcare market, causing several stocks associated with the virus to experience significant price fluctuations. While some companies, like Emergent Biosolutions and Bavarian Nordic, saw gains due to their involvement in vaccine production, others like SIGA Technologies faced setbacks after their antiviral treatment failed to meet a key trial endpoint.
The World Health Organization (WHO) has declared mpox a public health emergency of international concern, the highest level of alert, due to a severe outbreak in Congo. The outbreak has seen over 27,000 cases and 1,100 deaths since January 2023, and a new, rapidly spreading strain has raised global concerns.
The World Health Organization (WHO) has declared mpox a public health emergency of international concern due to the rapid spread of the disease in Eastern Democratic Republic of Congo and neighboring countries. The declaration triggers a global response to contain the outbreak and provides resources to affected countries.
The African Union has declared a public health emergency in response to the escalating mpox outbreak across the continent. The move, which marks the first use of the African CDC’s continental security powers, aims to mobilize resources and prevent further spread of the virus. The declaration follows a surge in cases, particularly in the Democratic Republic of Congo, where the virus was initially discovered in 1970.
A growing mpox outbreak in Africa, primarily in the Democratic Republic of Congo (DRC), has prompted the World Health Organization (WHO) to consider declaring a public health emergency of international concern. The outbreak, featuring a new, more deadly clade of the virus, has spread to neighboring countries and could pose a significant threat globally.
As the COVID-19 pandemic eases, experts warn of an alarming rise in drug-resistant superbugs that pose a greater danger than the coronavirus. This antimicrobial resistance (AMR) has become a major global health threat, prompting urgent action to tackle the issue within the next decade. Superbugs, which include bacteria, viruses, fungi, and parasites, are evolving and becoming resistant to existing antibiotics, making infections harder to treat and increasing the risk of severe illness, death, and spread. Unlike COVID-19, AMR does not fade away with immunity or vaccines and requires comprehensive strategies to address this pressing public health concern.
In a groundbreaking verdict, a federal jury has ruled that BNSF Railway contributed to the deaths of two individuals who were exposed to asbestos decades ago in the Montana town of Libby. The jury awarded $4 million each to the plaintiffs’ estates, finding that asbestos-contaminated vermiculite shipped through the town by BNSF played a role in their illnesses. The decision brings some accountability for the railroad’s past actions in Libby, where thousands have been sickened by asbestos exposure.